Table 1.
Major characteristics of patients
| Characteristic |
Cases |
Controls |
P
value |
|---|---|---|---|
| (n = 43) | (n = 67) | (two-tailed) | |
| Age (years) |
61.0 (50.0 to 72.5) |
60.5 (49.5 to 70.0) |
0.76 |
| Sex ratio (male/female) |
2.9 |
2.3 |
0.67 |
| Simplify Acute Physiology Score |
51.5 |
53.0 |
0.23 |
| Surgical patient |
37.2 |
20.3 |
0.07 |
| Abdominal surgery |
30.2 |
10.5 |
0.01 |
| Other surgery |
7.0 |
10.5 |
0.7 |
| Deep venous catheter |
97.7 |
96.8 |
1 |
| Broad-spectrum antibiotherapy |
100 |
98.4 |
1 |
| Corticoids |
30.2 |
39.7 |
0.41 |
| Vasopressor therapy |
65.1 |
57.8 |
0.55 |
| Exclusive parenteral nutrition |
37.2 |
4.7 |
<5 × 10-5 |
| Extrarenal epuration |
62.8 |
29.7 |
0.001 |
| Mechanical invasive ventilation |
100 |
98.4 |
1 |
| Duration of mechanical ventilation (days) |
31.5 (14.0 to 47.0) |
28.5 (15.5 to 42.0) |
0.5 |
| Neutropaenia |
7.0 |
6.4 |
1 |
| Antifungal therapy |
86.0 |
18.0 |
<5 × 10-5 |
| Fluconazole |
59.5 |
54.5 |
|
| Voriconazole |
13.5 |
0 |
|
| Caspofungin |
54.1 |
54.6 |
|
| Liposomal amphotericin-B |
5.4 |
9.1 |
|
| 5-Fluorocytosine |
2.7 |
0 |
|
| Bacteraemia |
58.1 |
27.0 |
0.002 |
| Distribution of bacteria |
|
|
|
| Gram-positive |
28.0 |
18.8 |
|
| Gram-negative |
56.0 |
56.2 |
|
| Mixed Gram-positive and Gram-negative |
16.0 |
25.0 |
|
| ICU duration of hospitalisation |
33.5 (23.5 to 60.0) |
29.0 (19.5 to 46.5) |
0.5 |
| ICU mortality |
62.8 |
38.5 |
0.02 |
| Hospital mortality | 65.1 | 44.6 | 0.05 |
Quantitative data are expressed as mean (25th to 75th quartile). Qualitative data are expressed as a percentage.